Targeting Enterobacter cloacae attenuates osteolysis by reducing ammonium in multiple myeloma.

Blood

State Key Laboratory of Experimental Hematology, Bioinformatics Center, National Clinical Research Center for Geriatric Disorders, Key Laboratory for Carcinogenesis and Invasion, Chinese Ministry of Education, Key Laboratory of Carcinogenesis, Chinese Ministry of Health, Furong Laboratory, Departmen

Published: April 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Multiple myeloma (MM)-induced bone disease affects not only patients' quality of life but also their overall survival. Our previous work demonstrated that the gut microbiome plays a crucial role in MM progression and drug resistance. However, the role of altered gut microbiota in MM bone disease remains unclear. In this study, we show that intestinal Enterobacter cloacae is significantly enriched in patients with MM with osteolysis. Through fecal microbial transplantation and single bacterial colonization experiments in a 5TGM1 MM mouse model, we found that intestinal colonization of E cloacae promotes osteolysis by increasing circulating ammonium levels. Elevated ammonium promotes osteoclastogenesis by increasing Trap protein levels in osteoclast precursors and by acetylating and stabilizing chemokine ligand 3 protein in MM cells. Inhibition of ammonium synthesis, using E cloacae with a deleted dcd gene, along with probiotic supplementation, alleviated osteolysis in MM. Overall, our work suggests that E cloacae promotes osteolysis in MM by synthesizing ammonium. This establishes a novel mechanism and potential intervention strategy for managing MM with osteolysis.

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood.2024025694DOI Listing

Publication Analysis

Top Keywords

enterobacter cloacae
8
multiple myeloma
8
bone disease
8
cloacae promotes
8
promotes osteolysis
8
osteolysis
6
cloacae
5
ammonium
5
targeting enterobacter
4
cloacae attenuates
4

Similar Publications

Background: Third-generation cephalosporin-resistant Enterobacterales is a recognized global concern. This study investigated the molecular epidemiology of β-lactamase genes and antimicrobial susceptibility patterns among ceftriaxone-resistant Enterobacterales causing intra-abdominal and urinary tract infections in Taiwan between 2009 and 2019.

Methods: Data from the SMART surveillance program were analyzed, including Enterobacterales isolates with ceftriaxone minimum inhibitory concentrations ≥4 μg/mL.

View Article and Find Full Text PDF

In Vitro synergy of Farnesyltransferase inhibitors in combination with colistin against ESKAPE bacteria.

PLoS One

September 2025

Faculty of Health, Institute of Pharmacology and Toxicology, Centre for Biomedical Education and Research (ZBAF), School of Medicine, Witten/Herdecke University, Witten, Germany.

The emergence of antibiotic resistance continues to pose a significant global challenge. Drug repurposing, wherein existing therapeutics are evaluated for new applications, offers a promising strategy to address this issue. Farnesyltransferase inhibitors (FTIs), initially developed for cancer therapy, have demonstrated antimicrobial activity against several gram-positive bacteria.

View Article and Find Full Text PDF

Herein, we report the isolation and characterization of an endophytic bacterium associated with the Berberis aristata roots to uncover bioactive compounds, particularly Antimicrobials, using submerged culture. The bacterial isolate was identified via 16S rDNA sequence analysis and characterized using morphological, microscopic, and biochemical techniques. It was identified as Bacillus toyonensis strain BAR1, a motile, gram-positive, halotolerant bacterium capable of producing yellow pigments.

View Article and Find Full Text PDF

Background: Metallo-β-lactamase (MBL)-producing Enterobacter cloacae complex (ECC) is an emerging threat associated with limited treatment options and increased mortality. This study aimed to describe the clinical and molecular characteristics, risk factors, and outcomes of MBL-producing ECC infections in Taiwan.

Methods: We conducted a retrospective cohort study at a tertiary hospital in central Taiwan from July 2022 to December 2023.

View Article and Find Full Text PDF

species are known to cause disseminated infections in immunocompromised hosts, typically in patients with hematological malignancies undergoing chemotherapy and those with a history of antifungal use. This case report described a non-neutropenic 85-year-old male patient with fungemia following polymicrobial bacteremia. He presented with fever and disturbed consciousness and was admitted for sepsis (day 1).

View Article and Find Full Text PDF